4//SEC Filing
Bodick Neil 4
Accession 0001209191-18-029521
CIK 0001419600other
Filed
May 10, 8:00 PM ET
Accepted
May 11, 4:07 PM ET
Size
8.7 KB
Accession
0001209191-18-029521
Insider Transaction Report
Form 4
Bodick Neil
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock option (right to buy)
2018-05-11−37,702→ 0 totalExercise: $0.16Exp: 2019-09-23→ Common Stock (37,702 underlying) - Exercise/Conversion
Common Stock
2018-05-11$0.16/sh+37,702$6,130→ 112,307 total
Holdings
- 388,683(indirect: By LLC)
Common Stock
- 1,000(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The shares are held by Versant Development Fund III, LLC. The Reporting Person is a manager and minority member of Versant Development Fund III, LLC. The Reporting Person disclaims any beneficial ownership of the shares held by Versant Development Fund III, LLC except to the extent of his pecuniary interest in these shares.
- [F2]The stock option is fully vested and exercisable.
Documents
Issuer
Flexion Therapeutics Inc
CIK 0001419600
Entity typeother
Related Parties
1- filerCIK 0001598099
Filing Metadata
- Form type
- 4
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 4:07 PM ET
- Size
- 8.7 KB